Physician profile
Eneh E Okoruwa
NPI 1568512564
$1,248.23
in general payments reported to CMS, 2019-2025
27 companies · $222 in 2025
The $222 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.28 · 2020: $24.05 · 2021: $123 · 2022: $222 · 2023: $78.12 · 2024: $512 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $410.68 | 2024-2025 | Zenpep |
| Glaxosmithkline, LLC. | $135.48 | 2022 | |
| Novo Nordisk INC | $95.19 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $53.86 | 2019-2024 | Freestyle Libre 3 |
| Insulet Corporation | $51.89 | 2021-2023 | Omnipod |
| Teva Pharmaceuticals USA, INC. | $51.18 | 2022-2024 | Austedo Xr, Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $49.21 | 2021-2025 | Caplyta |
| Lilly USA, LLC | $40.34 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $34.31 | 2024-2025 | |
| Abbvie INC. | $30.59 | 2021-2022 | |
| Amgen INC. | $27.85 | 2019-2022 | |
| Pfizer INC. | $27.40 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.27 | 2019-2024 | Xifaxan |
| Gilead Sciences, INC. | $22.05 | 2023 | Epclusa |
| Sumitomo Pharma America, INC. | $19.91 | 2025 | Gemtesa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.84 | 2025 | |
| Lundbeck LLC | $17.18 | 2024 | Vyepti |
| Ultragenyx Pharmaceutical INC. | $16.67 | 2021 | |
| Exact Sciences Corporation | $14.69 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $14.52 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.81 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $13.70 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $13.51 | 2024 | Dificid |
| Shire North American Group INC | $12.58 | 2019 | |
| Eisai INC. | $12.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.95 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eneh Okoruwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.